COMPOSITIONS THAT MODULATE COMPLEMENT FACTOR B AND METHODS OF USE THEREOF - Patent application
JP2024541771A5Pending Publication Date: 2026-06-15ADARX PHARMACEUTICALS INC
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- ADARX PHARMACEUTICALS INC
- Filing Date
- 2022-11-23
- Publication Date
- 2026-06-15
Abstract
Aspects of the present disclosure provide compounds, compositions and methods for modulating the expression or activity of complement factor B (CFB). In certain aspects, the compounds, compositions and methods of the present disclosure can be used to reduce the expression of CFB mRNA in a cell or animal. In certain aspects, the compounds, compositions and methods of the present disclosure can be used to reduce the expression of CFB protein in a cell or animal. In certain embodiments, the animal has or is at risk for a complement pathway-related disease, disorder or condition, or a symptom thereof.
Need to check novelty before this filing date? Find Prior Art